NewsBenzingaMarygold Companies Q4 EPS $(0.08) Down From $(0.04) YoY, Sales $6.925M Down From $7.200M YoY Marygold Companies Q4 EPS $(0.08) Down From $(0.04) YoY, Sales $6.925M Down From $7.200M YoY Benzinga 2026.09.18 21:35 (GMT+0) Open on Benzinga Other news B of A Securities Maintains Neutral on Biogen, Raises Price Target to $244 Voltus, Google Expand Agreement To Construct 1 GW Virtual Power Plant In PJM Grid B of A Securities Maintains Buy on Meta Platforms, Raises Price Target to $845 Acumen Pharmaceuticals To Present New Phase 2 ALTITUDE-AD Data For Sabirnetug In Early Alzheimer’s Disease At CTAD 2026 B of A Securities Maintains Buy on SpaceX, Raises Price Target to $275 Bread Financial Holdings Sees FY2026 Sales $4.037B vs $4.024B Est
Acumen Pharmaceuticals To Present New Phase 2 ALTITUDE-AD Data For Sabirnetug In Early Alzheimer’s Disease At CTAD 2026
